Tandem Diabetes Care, Inc. (TNDM)
USD 17.66
(-6.51%)
USD 17.66
(-6.51%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | -194.65 Million USD | -284.22% |
| 2022 | -72.31 Million USD | -235.83% |
| 2021 | 36.49 Million USD | 384.69% |
| 2020 | -13.02 Million USD | 52.42% |
| 2019 | -18.45 Million USD | 62.53% |
| 2018 | -109.15 Million USD | 29.09% |
| 2017 | -54.81 Million USD | 19.36% |
| 2016 | -72.26 Million USD | -13.11% |
| 2015 | -63.83 Million USD | 8.8% |
| 2014 | -71.16 Million USD | -63.56% |
| 2013 | -55.26 Million USD | -49.16% |
| 2012 | -28.45 Million USD | -35.3% |
| 2011 | -22.92 Million USD | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q2 | -26.66 Million USD | 29.02% |
| 2024 Q1 | -37.63 Million USD | -31.85% |
| 2023 Q3 | -31.54 Million USD | -9.69% |
| 2023 Q1 | 29.68 Million USD | 267.41% |
| 2023 FY | - USD | -284.22% |
| 2023 Q4 | -26.08 Million USD | 17.32% |
| 2023 Q2 | -28.75 Million USD | -196.89% |
| 2022 Q2 | -8.37 Million USD | 28.82% |
| 2022 Q4 | -17.73 Million USD | 58.55% |
| 2022 FY | - USD | -235.83% |
| 2022 Q1 | -11.76 Million USD | -192.38% |
| 2022 Q3 | -42.77 Million USD | -410.69% |
| 2021 Q4 | 12.73 Million USD | 18.85% |
| 2021 Q3 | 10.71 Million USD | 20.98% |
| 2021 Q1 | 92 Thousand USD | -99.51% |
| 2021 Q2 | 8.85 Million USD | 9529.35% |
| 2021 FY | - USD | 384.69% |
| 2020 Q4 | 18.66 Million USD | 1949.55% |
| 2020 FY | - USD | 52.42% |
| 2020 Q3 | -1 Million USD | 91.62% |
| 2020 Q2 | -12.03 Million USD | -9.26% |
| 2020 Q1 | -11.01 Million USD | -613.85% |
| 2019 Q4 | 2.14 Million USD | 159.46% |
| 2019 FY | - USD | 62.53% |
| 2019 Q1 | -8.8 Million USD | -1671.79% |
| 2019 Q2 | 429 Thousand USD | 104.87% |
| 2019 Q3 | -3.6 Million USD | -940.56% |
| 2018 Q3 | -13.81 Million USD | -12.35% |
| 2018 Q2 | -12.29 Million USD | 20.61% |
| 2018 Q1 | -15.48 Million USD | -61.61% |
| 2018 FY | - USD | 29.09% |
| 2018 Q4 | 560 Thousand USD | 104.05% |
| 2017 Q2 | -17.32 Million USD | 12.25% |
| 2017 Q1 | -19.73 Million USD | -47.9% |
| 2017 FY | - USD | 19.36% |
| 2017 Q4 | -9.58 Million USD | 15.84% |
| 2017 Q3 | -11.38 Million USD | 34.26% |
| 2016 Q1 | -17.78 Million USD | -58.52% |
| 2016 FY | - USD | -13.11% |
| 2016 Q2 | -15.56 Million USD | 12.5% |
| 2016 Q4 | -13.34 Million USD | 50.72% |
| 2016 Q3 | -27.08 Million USD | -74.02% |
| 2015 Q2 | -17.37 Million USD | 9.15% |
| 2015 FY | - USD | 8.8% |
| 2015 Q3 | -17.42 Million USD | -0.24% |
| 2015 Q1 | -19.12 Million USD | -9.3% |
| 2015 Q4 | -11.22 Million USD | 35.59% |
| 2014 Q2 | -18.31 Million USD | 7.94% |
| 2014 FY | - USD | -63.56% |
| 2014 Q4 | -17.5 Million USD | 1.72% |
| 2014 Q3 | -17.8 Million USD | 2.78% |
| 2014 Q1 | -19.89 Million USD | -26.31% |
| 2013 Q3 | -11.37 Million USD | 10.85% |
| 2013 Q2 | -12.75 Million USD | -99.85% |
| 2013 Q1 | -6.38 Million USD | 16.69% |
| 2013 FY | - USD | -49.16% |
| 2013 Q4 | -15.75 Million USD | -38.54% |
| 2012 Q4 | -7.66 Million USD | 13.45% |
| 2012 Q3 | -8.85 Million USD | 0.0% |
| 2012 FY | - USD | -35.3% |
| 2011 FY | - USD | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| Acutus Medical, Inc. | -13.48 Million USD | -1343.294% |
| Cerus Corporation | -26.53 Million USD | -633.558% |
| OrthoPediatrics Corp. | -8.38 Million USD | -2222.599% |
| PetVivo Holdings, Inc. | -10.49 Million USD | -1754.85% |
| Talis Biomedical Corporation | -66.04 Million USD | -194.734% |
| Vivos Therapeutics, Inc. | -16.67 Million USD | -1067.358% |
| Inogen, Inc. | -45.67 Million USD | -326.141% |
| Spectral AI, Inc. | -12.26 Million USD | -1487.482% |
| Nano-X Imaging Ltd. | -47.69 Million USD | -308.146% |
| CVRx, Inc. | -38.73 Million USD | -402.587% |
| DIH Holding US, Inc. Warrants | -3.52 Million USD | -5417.489% |
| Helius Medical Technologies, Inc. | -12.1 Million USD | -1507.805% |
| Orthofix Medical Inc. | -86.98 Million USD | -123.782% |
| Venus Concept Inc. | -26.11 Million USD | -645.441% |
| Accelerate Diagnostics, Inc. | -49.77 Million USD | -291.105% |
| Bioventus Inc. | -23.07 Million USD | -743.767% |
| BrainsWay Ltd. | -2.31 Million USD | -8323.064% |
| Envoy Medical, Inc. | -18.23 Million USD | -967.315% |
| electroCore, Inc. | -17.76 Million USD | -996.042% |
| IceCure Medical Ltd | -15.25 Million USD | -1176.188% |
| Lucid Diagnostics Inc. | -49.75 Million USD | -291.262% |
| Monogram Orthopaedics, Inc. | -16.85 Million USD | -1054.844% |
| MaxCyte, Inc. | -44.12 Million USD | -341.119% |
| NeuroOne Medical Technologies Corporation | -11.75 Million USD | -1555.812% |
| Nexalin Technology, Inc. | -5.69 Million USD | -3319.81% |
| PAVmed Inc | -75.74 Million USD | -157.0% |
| Rapid Micro Biosystems, Inc. | -53.75 Million USD | -262.099% |
| RxSight, Inc. | -41.03 Million USD | -374.345% |
| Sight Sciences, Inc. | -49.41 Million USD | -293.923% |
| SI-BONE, Inc. | -34.44 Million USD | -465.108% |
| TELA Bio, Inc. | -40.63 Million USD | -379.061% |
| TriSalus Life Sciences, Inc. | -58.29 Million USD | -233.9% |
| Treace Medical Concepts, Inc. | -39 Million USD | -399.018% |
| LivaNova PLC | 39.01 Million USD | 598.916% |
| 908 Devices Inc. | -34.02 Million USD | -472.1% |
| Alphatec Holdings, Inc. | -110.59 Million USD | -76.014% |
| Nemaura Medical Inc. | -7.28 Million USD | -2571.27% |
| NeuroPace, Inc. | -22.83 Million USD | -752.488% |
| LENSAR, Inc. | -8.71 Million USD | -2133.842% |
| Apyx Medical Corporation | -18.11 Million USD | -974.741% |
| Cutera, Inc. | -136.56 Million USD | -42.542% |
| STRATA Skin Sciences, Inc. | -3.38 Million USD | -5659.083% |
| BioSig Technologies, Inc. | -28.15 Million USD | -591.475% |
| Anika Therapeutics, Inc. | 2.51 Million USD | 7836.765% |
| ClearPoint Neuro, Inc. | -20.98 Million USD | -827.424% |
| Integra LifeSciences Holdings Corporation | 383.56 Million USD | 150.749% |
| Axonics, Inc. | 7.77 Million USD | 2603.627% |
| Outset Medical, Inc. | -153.78 Million USD | -26.574% |
| IRIDEX Corporation | -7.44 Million USD | -2513.547% |
| PROCEPT BioRobotics Corporation | -98.09 Million USD | -98.437% |
| IRadimed Corporation | 20.8 Million USD | 1035.822% |
| Tivic Health Systems, Inc. | -8.06 Million USD | -2314.5% |
| INVO Bioscience, Inc. | -6.88 Million USD | -2729.307% |
| Telesis Bio, Inc. | -40.49 Million USD | -380.718% |
| Viemed Healthcare, Inc. | 36.67 Million USD | 630.733% |
| Varex Imaging Corporation | 67.2 Million USD | 389.668% |
| Quipt Home Medical Corp. | 44.07 Million USD | 541.69% |
| Inspira Technologies Oxy B.H.N. Ltd. | -10.87 Million USD | -1690.773% |
| Pulmonx Corporation | -55.09 Million USD | -253.331% |
| Dynatronics Corporation | -976 Thousand USD | -19844.201% |
| Modular Medical, Inc. | -17.1 Million USD | -1038.145% |
| ReShape Lifesciences Inc. | -14.48 Million USD | -1243.852% |
| Semler Scientific, Inc. | 23.58 Million USD | 925.202% |
| InMode Ltd. | 196.28 Million USD | 199.172% |
| Bruker Corporation | 599 Million USD | 132.497% |
| Cytosorbents Corporation | -28.81 Million USD | -575.639% |
| DexCom, Inc. | 916.7 Million USD | 121.235% |
| Align Technology, Inc. | 799.03 Million USD | 124.361% |
| Viveve Medical, Inc. | -20.61 Million USD | -844.158% |
| ZimVie Inc. | 91.07 Million USD | 313.737% |
| Movano Inc. | -29.12 Million USD | -568.35% |
| Cytek Biosciences, Inc. | -4.4 Million USD | -4315.995% |
| Nexalin Technology, Inc. | -5.69 Million USD | -3319.81% |
| DIH Holdings US, Inc. Class A Common Stock | -3.52 Million USD | -5417.489% |
| Profound Medical Corp. | -27.12 Million USD | -617.67% |
| Insulet Corporation | 323.6 Million USD | 160.154% |
| enVVeno Medical Corporation | -25.01 Million USD | -678.068% |
| Surmodics, Inc. | 1.18 Million USD | 16485.269% |
| iCAD, Inc. | -6.56 Million USD | -2865.072% |
| Nuwellis, Inc. | -16.35 Million USD | -1090.126% |
| Biotricity, Inc. | -8.82 Million USD | -2104.928% |
| iRhythm Technologies, Inc. | -96.86 Million USD | -100.963% |
| Aethlon Medical, Inc. | -11.84 Million USD | -1542.798% |
| InspireMD, Inc. | -20.91 Million USD | -830.883% |
| PAVmed Inc. | -75.74 Million USD | -157.0% |
| BIOLASE, Inc. | -15.13 Million USD | -1185.798% |
| Beyond Air, Inc. | -59.03 Million USD | -229.754% |
| FONAR Corporation | 28.25 Million USD | 789.013% |
| AxoGen, Inc. | -13.32 Million USD | -1360.512% |
| Vivani Medical, Inc. | -26.6 Million USD | -631.573% |
| Tactile Systems Technology, Inc. | 24.54 Million USD | 893.191% |
| Inari Medical, Inc. | 7.11 Million USD | 2836.637% |
| UFP Technologies, Inc. | 72.74 Million USD | 367.596% |
| QT Imaging Holdings, Inc. | -3.38 Million USD | -5649.241% |
| Heart Test Laboratories, Inc. | -6.15 Million USD | -3062.072% |
| Tenon Medical, Inc. | -15.52 Million USD | -1153.587% |
| Autonomix Medical, Inc. Common Stock | -15.26 Million USD | -1175.102% |
| Co-Diagnostics, Inc. | -41.47 Million USD | -369.327% |
| AdaptHealth Corp. | -171.09 Million USD | -13.774% |
| Sintx Technologies, Inc. | -6.6 Million USD | -2849.348% |
| NanoVibronix, Inc. | -3.43 Million USD | -5566.87% |
| Quanterix Corporation | -38.08 Million USD | -411.072% |
| Inspira Technologies Oxy B.H.N. Ltd. | -10.87 Million USD | -1690.773% |
| Sensus Healthcare, Inc. | 30 Thousand USD | 648956.667% |
| Pacific Biosciences of California, Inc. | -277.28 Million USD | 29.798% |
| TransMedics Group, Inc. | -7.6 Million USD | -2460.266% |
| ReWalk Robotics Ltd. | -21.76 Million USD | -794.358% |
| NeuroMetrix, Inc. | -7.09 Million USD | -2643.267% |
| Hyperfine, Inc. | -47.06 Million USD | -313.627% |
| Establishment Labs Holdings Inc. | -58.3 Million USD | -233.848% |
| Biomerica, Inc. | -5.99 Million USD | -3148.073% |
| Bone Biologics Corporation | 479.57 Thousand USD | 40689.734% |
| AVITA Medical, Inc. | -39.56 Million USD | -391.959% |
| Bluejay Diagnostics, Inc. | -9.17 Million USD | -2022.08% |
| Silk Road Medical, Inc | -45.08 Million USD | -331.803% |